According to national guidelines, mild persistent asthma is defined by a need for β-agonist treatment more than 2 days per week (but less than daily), asthma-related nighttime awakenings more ...

While the exact cause of asthma is unknown, certain genetic factors can increase the risk of developing the disease.

Australia's Therapeutic Goods Administration (TGA) recently issued a safety alert requiring extra warnings to be included ...

Although cost-related asthma treatment nonadherence has declined in the US, nearly 1 in 6 patients are still nonadherent due to cost concerns.

Lifetime asthma prevalence was 32.3% in Black-white adults vs. 20.9% in monoracial Black adults and 16.3% in monoracial white adults. American Indian/Alaska Native-multiple adults also had ...

Primatene Mist inhalers provide temporary relief from mild, intermittent asthma symptoms ... and shortness of breath in ...

While many factors play a role in the onset of symptoms, frigid weather makes it especially difficult to breathe for people ...

In 2023, 47 adults in Northern Ireland died from asthma ... Asthma can cause wheezing, breathlessness, a tight chest and ...

Conclusions: Once-daily treatment with fluticasone propionate 100µg at night is as effective as 50µg twice daily in children with well controlled mild-to-moderate asthma.

BATURA enrolled patients with intermittent or mild persistent asthma, including those on short ... its use was restricted to adults aged 18 and over, despite an attempt by AZ and Avillion to ...